These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 23341533

  • 1. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.
    Corso G, Carvalho J, Marrelli D, Vindigni C, Carvalho B, Seruca R, Roviello F, Oliveira C.
    J Clin Oncol; 2013 Mar 01; 31(7):868-75. PubMed ID: 23341533
    [Abstract] [Full Text] [Related]

  • 2. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.
    Oliveira C, Sousa S, Pinheiro H, Karam R, Bordeira-Carriço R, Senz J, Kaurah P, Carvalho J, Pereira R, Gusmão L, Wen X, Cipriano MA, Yokota J, Carneiro F, Huntsman D, Seruca R.
    Gastroenterology; 2009 Jun 01; 136(7):2137-48. PubMed ID: 19269290
    [Abstract] [Full Text] [Related]

  • 3. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR, Prando EC, Quevedo FC, Neto FA, Rainho CA, Rogatto SR.
    BMC Cancer; 2006 Mar 02; 6():48. PubMed ID: 16512896
    [Abstract] [Full Text] [Related]

  • 4. E-cadherin expression in sporadic gastric cancer from Mexico: exon 8 and 9 deletions are infrequent events associated with poor survival.
    Gamboa-Dominguez A, Dominguez-Fonseca C, Chavarri-Guerra Y, Vargas R, Reyes-Gutierrez E, Green D, Quintanilla-Martinez L, Luber B, Busch R, Becker KF, Becker I, Höfler H, Fend F.
    Hum Pathol; 2005 Jan 02; 36(1):29-35. PubMed ID: 15712179
    [Abstract] [Full Text] [Related]

  • 5. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
    Bustos-Carpinteyro AR, Oliveira C, Sousa A, Oliveira P, Pinheiro H, Carvalho J, Magaña-Torres MT, Flores-Miramontes MG, Aguilar-Lemarroy A, Jave-Suárez LF, Peregrina-Sandoval J, Cruz-Ramos JA, Sánchez-López JY.
    BMC Cancer; 2019 Jan 14; 19(1):69. PubMed ID: 30642281
    [Abstract] [Full Text] [Related]

  • 6. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.
    Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simöes M.
    Oncogene; 2001 Mar 22; 20(12):1525-8. PubMed ID: 11313896
    [Abstract] [Full Text] [Related]

  • 7. Gastric cancer: new genetic developments.
    Lynch HT, Grady W, Suriano G, Huntsman D.
    J Surg Oncol; 2005 Jun 01; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [Abstract] [Full Text] [Related]

  • 8. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS, Vogelaar IP, Manders P, van der Kolk LE, Cats A, van Hest LP, Sijmons R, Aalfs CM, Ausems MG, Gómez García EB, Wagner A, Hes FJ, Arts N, Mensenkamp AR, van Krieken JH, Hoogerbrugge N, Ligtenberg MJ.
    Gastroenterology; 2015 Oct 01; 149(4):897-906.e19. PubMed ID: 26072394
    [Abstract] [Full Text] [Related]

  • 9. Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma.
    Jayaraj P, Sen S, Sharma A, Chosdol K, Kashyap S, Rai A, Pushker N, Bajaj MS, Ghose S.
    Br J Dermatol; 2012 Sep 01; 167(3):583-90. PubMed ID: 22458737
    [Abstract] [Full Text] [Related]

  • 10. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
    Ascaño JJ, Frierson H, Moskaluk CA, Harper JC, Roviello F, Jackson CE, El-Rifai W, Vindigni C, Tosi P, Powell SM.
    Mod Pathol; 2001 Oct 01; 14(10):942-9. PubMed ID: 11598162
    [Abstract] [Full Text] [Related]

  • 11. The unsolved enigma of CDH1 down-regulation in hereditary diffuse gastric cancer.
    Concolino P, Papa V, Mozzetti S, Ferlini C, Pacelli F, Martinelli E, Ricci R, Filippetti F, Scambia G, Doglietto GB.
    J Surg Res; 2004 Sep 01; 121(1):50-5. PubMed ID: 15313375
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
    Barber M, Murrell A, Ito Y, Maia AT, Hyland S, Oliveira C, Save V, Carneiro F, Paterson AL, Grehan N, Dwerryhouse S, Lao-Sirieix P, Caldas C, Fitzgerald RC.
    J Pathol; 2008 Nov 01; 216(3):295-306. PubMed ID: 18788075
    [Abstract] [Full Text] [Related]

  • 13. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer.
    Corso G, Pedrazzani C, Pinheiro H, Fernandes E, Marrelli D, Rinnovati A, Pascale V, Seruca R, Oliveira C, Roviello F.
    Eur J Cancer; 2011 Mar 01; 47(4):631-9. PubMed ID: 21106365
    [Abstract] [Full Text] [Related]

  • 14. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer.
    Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F.
    Prog Mol Biol Transl Sci; 2013 Mar 01; 116():337-59. PubMed ID: 23481202
    [Abstract] [Full Text] [Related]

  • 15. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer.
    Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S.
    Nat Genet; 2000 Sep 01; 26(1):16-7. PubMed ID: 10973239
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Promoter polymorphisms and methylation of E-cadherin (CDH1) and KIT in gastric cancer patients from northern Brazil.
    Borges Bdo N, Santos Eda S, Bastos CE, Pinto LC, Anselmo NP, Quaresma JA, Calcagno DQ, Burbano RM, Harada ML.
    Anticancer Res; 2010 Jun 01; 30(6):2225-33. PubMed ID: 20651373
    [Abstract] [Full Text] [Related]

  • 18. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
    Oue N, Motoshita J, Yokozaki H, Hayashi K, Tahara E, Taniyama K, Matsusaki K, Yasui W.
    J Pathol; 2002 Sep 01; 198(1):55-9. PubMed ID: 12210063
    [Abstract] [Full Text] [Related]

  • 19. Frequent promoter methylation of CDH1 in non-neoplastic mucosa of sporadic diffuse gastric cancer.
    Lee KH, Hwang D, Kang KY, Lee S, Kim DY, Joo YE, Lee JH.
    Anticancer Res; 2013 Sep 01; 33(9):3765-74. PubMed ID: 24023308
    [Abstract] [Full Text] [Related]

  • 20. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.
    Graziano F, Arduini F, Ruzzo A, Mandolesi A, Bearzi I, Silva R, Muretto P, Testa E, Mari D, Magnani M, Scartozzi M, Cascinu S.
    Ann Oncol; 2004 Mar 01; 15(3):489-92. PubMed ID: 14998854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.